U.S. Healthtech Stock News

Recent performance and market backdrop AT&T (T) has quietly outperformed over the past year, even as the stock has slipped around 4% this month and roughly 17% in the past 3 months, creating a more interesting entry point. See our latest analysis for AT&T. With the share price at $24.58, AT&T’s recent pullback contrasts with a solid year to date, and the stronger 1 year and multi year total shareholder returns suggest sentiment is cooling slightly rather than breaking the longer term recovery...

Recent Performance and Why Williams Companies Still Matters Williams Companies (WMB) has drifted lower over the past week, but zooming out tells a different story. The stock is still up solidly over the past year and has more than doubled over three years. See our latest analysis for Williams Companies. The latest pullback in Williams Companies’ share price, now around $59.74 after a weak week of trading, looks more like a pause than a reversal, given its solid year to date share price gains...

Victory Capital Holdings recently expanded its international offerings by adding three new UCITS funds through its partnership with Amundi, bringing its UCITS lineup to 22 and supporting its global growth ambitions. This move coincides with Total Assets Under Management reaching US$314.8 billion and client assets of US$317.7 billion, underscoring the scale behind its push into cross-border fund distribution. Next, we’ll examine how the new Amundi-Distributed UCITS range could reshape Victory...

In December 2025, BWX Technologies reported shipping its TRISO nuclear fuel to Idaho National Laboratory for the U.S. Army’s Project Pele microreactor and was named, alongside Laurentis Energy Partners and Canadian Nuclear Partners, as Owner’s Engineer for Bulgaria’s planned AP1000 units at the Kozloduy nuclear plant under a multi‑year, hundreds‑of‑millions‑of‑euros contract. Together, these developments underline BWXT’s role at both ends of the nuclear spectrum, leading‑edge defense...

Why Freshpet Stock Has Caught Investor Attention Freshpet (FRPT) has quietly staged a comeback, with shares up roughly 14% over the past month even though the stock is still down sharply year to date. See our latest analysis for Freshpet. That recent momentum, reflected in a 30 day share price return of 14.04% and a three year total shareholder return of 14.85%, is encouraging but still sits against a steep year to date share price decline and weaker one year total shareholder returns. If...

In recent months, analysts and investors have highlighted Birkenstock Holding’s preannounced fiscal 2025 revenue growth, expansion in Western and Asia Pacific markets, and acquisitions of a German production facility and its Australian distributor as key developments supporting its brand momentum. An interesting angle is how Birkenstock’s growing resonance with younger consumers, under CEO Oliver Reichart and majority owner LVMH’s family office, is reshaping its image from heritage comfort...

If you have been wondering whether SouthState Bank at around $96 a share is quietly turning into a value opportunity, you are not alone. This is exactly what we are going to unpack. The stock has climbed 4.3% over the last week and 7.2% over the past month, even though it is still down 0.9% year to date and 9.4% over the last year. This hints at shifting expectations after a tougher stretch, despite a solid 39.3% 3 year and 46.9% 5 year run. Recent headlines around regional banks, including...

TransDigm Group (TDG) just delivered a strong quarterly earnings report, with higher net sales, rising net income, and upbeat fiscal 2026 guidance that reinforces its growth story across commercial and defense aviation. See our latest analysis for TransDigm Group. Even after a strong quarter and the Simmonds Precision Products acquisition, TransDigm’s 1 year total shareholder return of 9.89 percent and powerful 3 year total shareholder return of 150.04 percent show momentum is still firmly in...

Ouster (OUST) just added seasoned operator Phillip Eyler to its board and Compensation Committee, a governance move that lines up neatly with what analysts see as a long runway in automotive, industrial, and robotics growth. See our latest analysis for Ouster. The latest pullback, including a 1 day share price return of minus 8.1 percent, comes after a powerful year to date share price return of roughly 96 percent and a 1 year total shareholder return of about 167 percent. This suggests...

If you have been wondering whether BioCryst Pharmaceuticals at around $7.57 is a bargain or a value trap, you are not alone. This article is aimed squarely at that question. Despite a choppy few years, the stock has edged up about 5.4% over the last month, while still roughly flat over the past year and well below levels from three years ago. That hints that sentiment might be cautiously shifting, but the long term story is still being debated. Recent headlines have focused on BioCryst's...

Wondering if Domino's Pizza is still a hot slice for your portfolio or if the best gains are already baked in? This breakdown will help you figure out what you are really paying for the stock today. Shares are up 3.6% over the last week and 6.9% over the past month, even though they are still slightly down at -0.7% year to date and -3.6% over the last year, which suggests sentiment is shifting after a softer stretch. Recently, investors have been reacting to Domino's ongoing push into tech...

Earlier this week, Gemini Space Station, Inc. announced that its affiliate Gemini Titan, LLC has received long-sought CFTC approval to operate as a Designated Contract Market, allowing it to launch regulated, event-based prediction markets for U.S. customers across areas such as crypto, elections, sports, and geopolitics. This five-year licensing journey marks Gemini’s entry into a tightly regulated prediction market arena previously dominated by a few incumbents, positioning its platform as...

Why Ingredion Stock Has Investors Taking a Second Look Ingredion (INGR) has quietly outperformed over the past 5 years, even as the stock has slid this year. That mix of long term strength and recent weakness now has value investors circling. See our latest analysis for Ingredion. Over the past year, Ingredion’s share price return has been negative as investors reassessed cyclical risks, yet its five year total shareholder return above 60% shows the longer term trend remains constructive...

Wondering if Vicor is still worth chasing after its big run, or if the smart move now is to sit tight and wait for a better entry point? Let us unpack what the market might be pricing in. The stock has climbed 1.0% over the last week, 3.7% over the past month, and is up an eye catching 102.8% year to date, after gaining 79.3% over the past year and 83.1% over three years, even though the five year return is a more modest 7.2%. Behind these moves, investors have been reacting to Vicor’s...

During the third quarter, New York City-based Summit Street Capital Management increased its Core Natural Resources stake by 81,170 shares, bringing its holding to 342,155 shares valued at about US$28.6 million and making the company its fourth-largest position. This sizeable addition by a major institutional investor highlights growing confidence in Core Natural Resources’ integrated mining-and-terminal model, capital return approach, and ability to preserve cash flow amid operational...

Recently, hedge fund Peconic Partners concentrated more than very large of its long exposure in infrastructure names including MasTec, betting on companies that build power lines and fiber networks underpinning AI and high-speed internet demand. This heightened institutional focus comes even as MasTec contends with a 12.9% gross margin and weaker free cash flow margins, highlighting how enthusiasm for AI-related infrastructure can outweigh near-term profitability concerns. We’ll now examine...

Trinity Capital (TRIN) just caught investor attention after two firms initiated bullish coverage on the stock, alongside better than expected third quarter earnings, with revenue jumping roughly 22% from a year earlier. See our latest analysis for Trinity Capital. Those upbeat initiations and the revenue surprise seem to be stabilizing sentiment, with the share price now at $15.18 and a 1 year total shareholder return of 19.2% signaling gradually building momentum despite recent quarterly...

If you are wondering whether Nextpower is still a smart buy after its huge run up, or if you have already missed the sweet spot, this article will walk through what the current price really implies. Despite pulling back around 4.2% over the last week and 10.1% over the past month, the stock is still up about 119.6% year to date and 144.6% over the last year. This naturally raises questions about whether the market has gotten ahead of itself. Recent headlines have focused on Nextpower...

Butler National (BUKS) has put up another solid quarter, with Q2 2026 revenue of about $23.3 million and net income of $6.0 million translating to basic EPS of roughly $0.09. This is underpinned by a trailing net profit margin of 19% and earnings growth of 29.2% over the past 12 months. The company has seen revenue move from around $21.4 million and EPS of about $0.05 in Q2 2025 to $23.3 million and $0.09 in Q2 2026, against a backdrop of five year compound earnings growth of 31.6%. This sets...

HCI Group (HCI) just picked up a more favorable Zacks Rank after analysts sharply raised their full year earnings forecasts, a shift in expectations that helps explain the stock’s strong year to date climb. See our latest analysis for HCI Group. The upgraded earnings outlook seems to be feeding into a powerful trend, with HCI’s share price climbing to $187.47 and delivering a roughly 64% year to date share price return, backed by a 3 year total shareholder return near 500%. This suggests that...

Incubator expansion puts Charles River in focus Charles River Laboratories International (CRL) has kicked off the second cohort of its Cell and Gene Therapy Incubator Program, spotlighting its role as an enabler for early stage biotech rather than a traditional contract research vendor. By opening its scientific talent, regulatory know how, and global lab footprint to six emerging therapy developers, the company is leaning into a partnership model that could deepen client stickiness and...

Recent performance sets the stage Intuitive Surgical (ISRG) has pulled back about 6% over the past week and roughly 5% over the past month, even though shares are still up more than 20% in the past 3 months. See our latest analysis for Intuitive Surgical. Zooming out, the recent pullback sits against a still impressive backdrop, with the 3 year total shareholder return more than doubling even as short term share price momentum has cooled around the current 542.32 dollars level. This hints at...

Earlier this week, Citizens Financial Group reported third-quarter results with revenue and earnings per share slightly above analyst expectations while its subsidiary Citizens Bank, N.A. lowered the prime lending rate from 7% to 6.75% effective 11 December 2025. This combination of a solid quarter and a rate cut aimed at easing borrowing costs highlights how Citizens is trying to balance profitability with support for customers amid changing financial conditions. Next, we’ll examine how...

Kimberly-Clark (KMB) has quietly slipped about 19% over the past 3 months, even as revenue and net income keep growing. That disconnect is exactly what makes the stock interesting right now. See our latest analysis for Kimberly-Clark. Zooming out, the 1 year total shareholder return of minus 18.25% and the year to date share price return of minus 21.04% tell a clear story of fading momentum despite steady fundamental progress. If Kimberly-Clark has you rethinking where defensiveness and...